Comments
Loading...
Channel Therapeutics (CHRO) Forecast
NewsEarningsChannel Therapeutics (CHRO) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestEdge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Channel Therapeutics Stock Price, Quotes and Forecasts | AMEX:CHRO | Benzinga
Explore Channel Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CHRO.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Channel Therapeutics (CHRO) stock?
You can purchase shares of Channel Therapeutics (AMEX:CHRO) through any online brokerage.
Who are Channel Therapeutics (CHRO) competitors?
Other companies in Channel Therapeutics’s space includes: Intensity Therapeutics (NASDAQ:INTS), CARISMA Therapeutics (NASDAQ:CARM), TransCode Therapeutics (NASDAQ:RNAZ), Indaptus Therapeutics (NASDAQ:INDP) and GT Biopharma (NASDAQ:GTBP).
What is the forecast, or price target, for Channel Therapeutics (CHRO) stock?
There is no analysis for Channel Therapeutics to provide a consensus price target.
What is the current price for Channel Therapeutics (CHRO)?
The stock price for Channel Therapeutics (AMEX: CHRO) is $1.11 last updated May 13, 2025 at 12:38 PM EDT.
Does Channel Therapeutics (CHRO) pay a dividend?
There are no upcoming dividends for Channel Therapeutics.
When is Channel Therapeutics (AMEX:CHRO) reporting earnings?
Channel Therapeutics’s Q2 earnings are confirmed for Tuesday, August 12, 2025.
Is Channel Therapeutics (CHRO) going to split?
There is no upcoming split for Channel Therapeutics.
What sector and industry does Channel Therapeutics (CHRO) operate in?
Channel Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.
